Novo Seeds
Investor profile
Novo Seeds has backed 4 European tech companies across 5 funding rounds between 2018 and 2022, joining rounds totalling €165M. Most active in Healthtech. Data as of 4 Nov 2026.
Also recorded as: Novo SEEDs
Deals
5
distinct rounds
Companies
4
backed
Active span
2018–2022
5 yrs
Total round €
€165M
sum of rounds joined
Deals by year
distinct rounds / yearNovo Seeds — deals by year — interactive chart.
Data table
| Novo Seeds — deals by year | |
|---|---|
| 2018 | 2 |
| 2021 | 2 |
| 2022 | 1 |
Top sectors
by dealsNovo Seeds — top sectors — interactive chart.
Data table
| Novo Seeds — top sectors | |
|---|---|
| Healthtech | 5 |
Stages
by dealsNovo Seeds — stages — interactive chart.
Data table
| Novo Seeds — stages | |
|---|---|
| Other | 4 |
| Series C | 1 |
Countries
by dealsNovo Seeds — countries — interactive chart.
Data table
| Novo Seeds — countries | |
|---|---|
| Denmark | 4 |
| Netherlands | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Galecto Biotech | Denmark | 1 | €79M |
| Northsea Therapeutics | Netherlands | 1 | €71M |
| Biosyntia | Denmark | 2 | €16M |
| ISD Immunotech | Denmark | 1 | €0 |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Galecto Biotech | Series C | €79M | 2018-10 |
| Northsea Therapeutics | Other | €71M | 2021-12 |
| Biosyntia | Other | €12M | 2022-07 |
| Biosyntia | Other | €4.0M | 2018-02 |